These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67 related articles for article (PubMed ID: 2790879)
21. [Pharmacotherapy of portal hypertension]. Drazná E Vnitr Lek; 1995 Mar; 41(3):185-8. PubMed ID: 7762177 [TBL] [Abstract][Full Text] [Related]
22. Similarity of arterial and intravenous vasopressin on portal and systemic hemodynamics. Barr JW; Lakin RC; Rösch J Gastroenterology; 1975 Jul; 69(1):13-9. PubMed ID: 1150017 [TBL] [Abstract][Full Text] [Related]
23. The effect of vasopressin and triglycyl lysine vasopressin (glypressin) on the splanchnic circulation in cirrhotic patients with portal hypertension. Rabol A; Juhl E; Schmidt A; Winkler K Digestion; 1976; 14(3):285-9. PubMed ID: 955334 [TBL] [Abstract][Full Text] [Related]
24. Haemodynamic response to intravenous vasopressin and nitroglycerin in portal hypertension. Westaby D; Gimson A; Hayes PC; Williams R Gut; 1988 Mar; 29(3):372-7. PubMed ID: 3128465 [TBL] [Abstract][Full Text] [Related]
25. [Propranolol and 5-isosorbide mononitrate in patients with cirrhosis: systemic and portal hemodynamic events]. Castaño G; Viudez P; Sookoian S; Carlevaro O; Riccitelli M; Frider B Gastroenterol Hepatol; 2000; 23(6):275-81. PubMed ID: 15324622 [TBL] [Abstract][Full Text] [Related]
26. Acute hemodynamic effects of octreotide and terlipressin in patients with cirrhosis: a randomized comparison. Baik SK; Jeong PH; Ji SW; Yoo BS; Kim HS; Lee DK; Kwon SO; Kim YJ; Park JW; Chang SJ; Lee SS Am J Gastroenterol; 2005 Mar; 100(3):631-5. PubMed ID: 15743362 [TBL] [Abstract][Full Text] [Related]
27. Estimating effect of terlipressin on portal pressure in cirrhosis by observing hepatic vein Doppler waveform. Hussain Q; Haider S; Solangi NM; Ali L; Liaquat H; Ahmed F; Shahbaz S J Pak Med Assoc; 2013 May; 63(5):604-8. PubMed ID: 23757989 [TBL] [Abstract][Full Text] [Related]
28. Effect of peroral administration of isosorbide dinitrate on portal pressure and blood flow in patients with cirrhosis of the liver. Cervinka J; Kordac V; Kalab M J Int Med Res; 1989; 17(6):560-4. PubMed ID: 2628133 [TBL] [Abstract][Full Text] [Related]
29. Effects of propranolol on portal hemodynamics in patients with chronic liver disease. Ohnishi K; Nakayama T; Saito M; Hatano H; Tsukamoto T; Terabayashi H; Sugita S; Wada K; Nomura F; Koen H Am J Gastroenterol; 1985 Feb; 80(2):132-5. PubMed ID: 3881933 [TBL] [Abstract][Full Text] [Related]
31. Hemodynamic effects of continuous versus bolus infusion of terlipressin for portal hypertension: a randomized comparison. Ding C; Wu X; Fan X; He C; Li J J Gastroenterol Hepatol; 2013 Jul; 28(7):1242-6. PubMed ID: 23489113 [TBL] [Abstract][Full Text] [Related]
32. Hepatic flow parameters measured with MR imaging and Doppler US: correlations with degree of cirrhosis and portal hypertension. Annet L; Materne R; Danse E; Jamart J; Horsmans Y; Van Beers BE Radiology; 2003 Nov; 229(2):409-14. PubMed ID: 12970464 [TBL] [Abstract][Full Text] [Related]
33. [Effect of somatostatin on portal and hepatic hemodynamics and portal venous pressure in cirrhotic patients with portal hypertension]. Zhu J; Leng X; Feng H; Li S; Gan L; Zhang Y; Du R Zhonghua Wai Ke Za Zhi; 1998 Jul; 36(7):433-5. PubMed ID: 11825434 [TBL] [Abstract][Full Text] [Related]
34. Portohepatic pressures, hepatic function, and blood gases in the combination of nitroglycerin and vasopressin: search for additive effects in cirrhotic portal hypertension. Iwao T; Toyonaga A; Ikegami M; Sumino M; Oho K; Sakaki M; Nishizono M; Tanikawa K Am J Gastroenterol; 1992 Jun; 87(6):719-24. PubMed ID: 1590307 [TBL] [Abstract][Full Text] [Related]
35. Should we routinely measure portal pressure in patients with cirrhosis, using hepatic venous pressure gradient (HVPG) as a guide for prophylaxis and therapy of bleeding and rebleeding? No. Thalheimer U; Bellis L; Puoti C; Burroughs AK Eur J Intern Med; 2011 Feb; 22(1):5-7. PubMed ID: 21238884 [TBL] [Abstract][Full Text] [Related]
36. Hemodynamic evaluation of the addition of isosorbide-5-mononitrate to nadolol in cirrhotic patients with insufficient response to the beta-blocker alone. Merkel C; Sacerdoti D; Bolognesi M; Enzo E; Marin R; Bombonato G; Angeli P; Gatta A Hepatology; 1997 Jul; 26(1):34-9. PubMed ID: 9214449 [TBL] [Abstract][Full Text] [Related]
37. Comparative randomized study on efficacy of losartan versus propranolol in lowering portal pressure in decompensated chronic liver disease. Agasti AK; Mahajan AU; Phadke AY; Nathani PJ; Sawant P J Dig Dis; 2013 May; 14(5):266-71. PubMed ID: 23280243 [TBL] [Abstract][Full Text] [Related]
38. Effects of esophageal transection combined with splenectomy on portal hemodynamics. Saito M; Ohnishi K; Tanaka H; Sato S; Okuda K; Hirashima T; Hara T Am J Gastroenterol; 1987 Jan; 82(1):16-9. PubMed ID: 3799575 [TBL] [Abstract][Full Text] [Related]
39. [Effects of two different dosages of octreotide on portal pressure and hepatic hemodynamics in cirrhotic portal hypertensive patients after portal-azygous devascularization and splenectomy]. Lu SC; Meng FK; Ding HG; Zhang JG; Ding L; Wang SZ Zhonghua Nei Ke Za Zhi; 2007 Apr; 46(4):290-3. PubMed ID: 17637266 [TBL] [Abstract][Full Text] [Related]
40. Effect of vasopressin on portal venous pressure. Kallio H; Lempinen M Acta Chir Scand; 1983; 149(1):49-52. PubMed ID: 6601347 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]